Trial intelligence / Profile preview

MAG-PAPER: Magnesium for Pain in Severe PAOD

NCT02455726Unknown

Sponsor: ASST Spedali Civili di Brescia
Start: Sep 2015
Primary completion: Dec 2017

Overview

Randomised, double-blind trial in peripheral arterial occlusive disease (PAOD), sponsored by ASST Spedali Civili di Brescia. Primary endpoint: Oxycodone dosage needed to achieve satisfactory analgesia at 14 days. Status: unknown.

Conditions

peripheral arterial occlusive disease (PAOD)

Beyond the preview

Go deeper on NCT02455726.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02455726.